毛怀东 侣丽萍 陈锦河 黄石标 郑壁伟
(清远市中医院,广东 清远,511500)
中图分类号:R289 文献标识码:A 文章编号:1674-7860(2016)18-0093-03 证型:IDGB
【摘 要】目的:观察苇茎汤合小陷胸汤治疗重症肺炎患者的作用效果和机制。方法:选取我院2012年6月—2015年6月收治的重症肺炎患者103例作为研究对象,将其按照对照、均衡、随机原则分为两组,对照组55例,采用常规西医治疗,治疗组48例,在对照组的基础上采用苇茎汤合小陷胸汤治疗,分别对两组患者的治疗有效率、病死率、不良反应发生率、住院时间,治疗1 d、3 d、7 d、14d后PCT、CRP、WBC及OI等指标进行比较。结果:治疗组和对照组患者的临床治疗有效率分别为88.2%和72.5%,病死率分别为4.2%和16.4%,不良反应发生率分别为88.2%和72.5%,住院时间分别为(16.9±4.3)d和(21.4±6.7)d,治疗组均显著优于对照组,差异有统计学意义(P<0.05)。治疗组患者治疗7~14 d后的PCT,CRP,WBC显著高于对照组,而OI显著低于对照组,比较也均有统计学差异(P<0.05)。结论:苇茎汤合小陷胸汤治疗重症肺炎有利于提高治疗效果和缩短住院时间,患者恢复快,治疗安全性好,值得临床推广应用。
【关键词】苇茎汤合小陷胸汤;重症肺炎;中西医结合;临床效果
【Abstract】Objective: To observe the effect and mechanism of WeiJingdecoction and the Xiaoxianxiong decoction on severe pneumonia. Methods: 103 patientsrandomLy divided into two groups, the control group was given routine westernmedicine (55 cases) , the treatment group was given the WeiJing decoction andthe Xiaoxianxiong decoction more (48 cases) , 55 cases in control group,treated with routine western medicine, treatment group (48 cases). Respectivelyfor the treatment of patients with efficiency, adverse reaction incidence,mortality, length of stay, after treatment of 1 d, 3d, 7 d, 14 d the PCT, CRP,WBC and OI, indices were compared. Results: the total efficiency in thetreatment group (88.2%) and in the control group (72.5%) , the mortality in thetreatment group (4.2%) and in the control group (16.4%) , the incidence ofadverse reactions in the treatment group (88.2%) and in the control group(72.5%) , length of hospital stay in the treatment group (16.9±4.3) d and in the control group (21.4±6.7) d, the treatment was better than thecontrol group, the difference was statistically significant (P<0.05). Aftertreatment 7~14 d PCT, CRP,WBC in treatment was higher; the OI was lower, the difference was statistically significant (P<0.05).Conclusion: WeiJing decoction andthe Xiaoxianxiong decoction shows obvious effects on Severe pneumonia, and highsafety, worthy of promotion.
【Keywords】WeiJing decoction and the Xiaoxianxiong decoction; Severepneumonia; The integrative medicine; Clinical effect
doi:10.3969/j.issn.1674-7860.2016.18.044
![]() |